PortfoliosLab logo
FBIOX vs. FNCMX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FBIOX and FNCMX is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

FBIOX vs. FNCMX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity NASDAQ Composite Index Fund (FNCMX). The values are adjusted to include any dividend payments, if applicable.

700.00%800.00%900.00%1,000.00%1,100.00%December2025FebruaryMarchAprilMay
707.20%
967.03%
FBIOX
FNCMX

Key characteristics

Sharpe Ratio

FBIOX:

-0.28

FNCMX:

0.41

Sortino Ratio

FBIOX:

-0.22

FNCMX:

0.74

Omega Ratio

FBIOX:

0.97

FNCMX:

1.10

Calmar Ratio

FBIOX:

-0.20

FNCMX:

0.43

Martin Ratio

FBIOX:

-0.62

FNCMX:

1.44

Ulcer Index

FBIOX:

10.55%

FNCMX:

7.24%

Daily Std Dev

FBIOX:

23.69%

FNCMX:

25.59%

Max Drawdown

FBIOX:

-71.96%

FNCMX:

-55.71%

Current Drawdown

FBIOX:

-28.16%

FNCMX:

-11.94%

Returns By Period

In the year-to-date period, FBIOX achieves a -9.23% return, which is significantly lower than FNCMX's -8.00% return. Over the past 10 years, FBIOX has underperformed FNCMX with an annualized return of 2.40%, while FNCMX has yielded a comparatively higher 13.95% annualized return.


FBIOX

YTD

-9.23%

1M

2.79%

6M

-21.54%

1Y

-6.43%

5Y*

1.11%

10Y*

2.40%

FNCMX

YTD

-8.00%

1M

13.68%

6M

-6.31%

1Y

9.26%

5Y*

15.24%

10Y*

13.95%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FBIOX vs. FNCMX - Expense Ratio Comparison

FBIOX has a 0.69% expense ratio, which is higher than FNCMX's 0.29% expense ratio.


Risk-Adjusted Performance

FBIOX vs. FNCMX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBIOX
The Risk-Adjusted Performance Rank of FBIOX is 77
Overall Rank
The Sharpe Ratio Rank of FBIOX is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of FBIOX is 77
Sortino Ratio Rank
The Omega Ratio Rank of FBIOX is 88
Omega Ratio Rank
The Calmar Ratio Rank of FBIOX is 66
Calmar Ratio Rank
The Martin Ratio Rank of FBIOX is 77
Martin Ratio Rank

FNCMX
The Risk-Adjusted Performance Rank of FNCMX is 4444
Overall Rank
The Sharpe Ratio Rank of FNCMX is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of FNCMX is 4444
Sortino Ratio Rank
The Omega Ratio Rank of FNCMX is 4343
Omega Ratio Rank
The Calmar Ratio Rank of FNCMX is 5151
Calmar Ratio Rank
The Martin Ratio Rank of FNCMX is 4444
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FBIOX vs. FNCMX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity NASDAQ Composite Index Fund (FNCMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current FBIOX Sharpe Ratio is -0.28, which is lower than the FNCMX Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of FBIOX and FNCMX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.28
0.41
FBIOX
FNCMX

Dividends

FBIOX vs. FNCMX - Dividend Comparison

FBIOX's dividend yield for the trailing twelve months is around 1.33%, more than FNCMX's 0.66% yield.


TTM20242023202220212020201920182017201620152014
FBIOX
Fidelity Select Biotechnology Portfolio
1.33%1.21%0.45%0.00%14.48%19.46%8.89%11.18%1.41%3.42%6.71%10.77%
FNCMX
Fidelity NASDAQ Composite Index Fund
0.66%0.61%0.67%0.88%0.47%0.67%4.41%1.93%0.73%1.01%0.89%1.24%

Drawdowns

FBIOX vs. FNCMX - Drawdown Comparison

The maximum FBIOX drawdown since its inception was -71.96%, which is greater than FNCMX's maximum drawdown of -55.71%. Use the drawdown chart below to compare losses from any high point for FBIOX and FNCMX. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2025FebruaryMarchAprilMay
-28.16%
-11.94%
FBIOX
FNCMX

Volatility

FBIOX vs. FNCMX - Volatility Comparison

The current volatility for Fidelity Select Biotechnology Portfolio (FBIOX) is 12.27%, while Fidelity NASDAQ Composite Index Fund (FNCMX) has a volatility of 14.39%. This indicates that FBIOX experiences smaller price fluctuations and is considered to be less risky than FNCMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%December2025FebruaryMarchAprilMay
12.27%
14.39%
FBIOX
FNCMX